Cargando…

The Antiasthma Medication Ciclesonide Suppresses Breast Cancer Stem Cells through Inhibition of the Glucocorticoid Receptor Signaling-Dependent YAP Pathway

Ciclesonide is an FDA-approved glucocorticoid used to treat asthma and allergic rhinitis. However, whether it has anticancer and anti-cancer stem cell (CSC) effects is unknown. This study focused on investigating the effect of ciclesonide on breast cancer and CSCs and determining its underlying mech...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Su-Lim, Choi, Hack Sun, Kim, Ji-Hyang, Lee, Dong-Sun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766992/ https://www.ncbi.nlm.nih.gov/pubmed/33352739 http://dx.doi.org/10.3390/molecules25246028

Ejemplares similares

The FDA-Approved Anti-Asthma Medicine Ciclesonide Inhibits Lung Cancer Stem Cells through Hedgehog Signaling-Mediated SOX2 Regulation
por: Choi, Hack Sun, et al.
Publicado: (2020)

Caudatin Isolated from Cynanchum auriculatum Inhibits Breast Cancer Stem Cell Formation via a GR/YAP Signaling
por: Zhen, Xing, et al.
Publicado: (2020)

Evaluation of the community pharmacist’s behavior towards a prescription of antidiabetic and antiasthma drugs
por: Alomar, Muaed J., et al.
Publicado: (2011)

Disruption of the NF-κB/IL-8 Signaling Axis by Sulconazole Inhibits Human Breast Cancer Stem Cell Formation
por: Choi, Hack Sun, et al.
Publicado: (2019)

Machilin D, a Lignin Derived from Saururus chinensis, Suppresses Breast Cancer Stem Cells and Inhibits NF-κB Signaling
por: Zhen, Xing, et al.
Publicado: (2020)

Dihydrotanshinone-Induced NOX5 Activation Inhibits Breast Cancer Stem Cell through the ROS/Stat3 Signaling Pathway
por: Kim, Su-Lim, et al.
Publicado: (2019)

Ciclesonide for the treatment of asthma
por: Dahl, Ronald
Publicado: (2006)

The PAK1-Stat3 Signaling Pathway Activates IL-6 Gene Transcription and Human Breast Cancer Stem Cell Formation
por: Kim, Ji-Hyang, et al.
Publicado: (2019)

Inhibitory Effects of Tangeretin, a Citrus Peel-Derived Flavonoid, on Breast Cancer Stem Cell Formation through Suppression of Stat3 Signaling
por: Ko, Yu-Chan, et al.
Publicado: (2020)

Coriolic Acid (13-(S)-Hydroxy-9Z, 11E-octadecadienoic Acid) from Glasswort (Salicornia herbacea L.) Suppresses Breast Cancer Stem Cell through the Regulation of c-Myc
por: Ko, Yu-Chan, et al.
Publicado: (2020)

Betavulgarin Isolated from Sugar Beet (Beta vulgaris) Suppresses Breast Cancer Stem Cells through Stat3 Signaling
por: Liu, Ren, et al.
Publicado: (2020)

Network Pharmacology-Based Analysis of the Underlying Mechanism of Hyssopus cuspidatus Boriss. for Antiasthma: A Characteristic Medicinal Material in Xinjiang
por: Liu, Rongchang, et al.
Publicado: (2021)

Triterpene Acid (3-O-p-Coumaroyltormentic Acid) Isolated From Aronia Extracts Inhibits Breast Cancer Stem Cell Formation through Downregulation of c-Myc Protein
por: Choi, Hack Sun, et al.
Publicado: (2018)

Intranasal ciclesonide for allergic rhinitis
por: Williams, Ben, et al.
Publicado: (2008)

Uptake and metabolism of ciclesonide and retention of desisobutyryl-ciclesonide for up to 24 hours in rabbit nasal mucosa
por: Sato, Hideyuki, et al.
Publicado: (2007)

Plant Volatile, Phenylacetaldehyde Targets Breast Cancer Stem Cell by Induction of ROS and Regulation of Stat3 Signal
por: Choi, Hack Sun, et al.
Publicado: (2020)

Profile of ciclesonide for the maintenance treatment of asthma
por: Singas, Effie, et al.
Publicado: (2011)

6-Methoxymellein Isolated from Carrot (Daucus carota L.) Targets Breast Cancer Stem Cells by Regulating NF-κB Signaling
por: Liu, Ren, et al.
Publicado: (2020)

Glucocorticoid receptor signalling activates YAP in breast cancer
por: Sorrentino, Giovanni, et al.
Publicado: (2017)

Primaquine Inhibits the Endosomal Trafficking and Nuclear Localization of EGFR and Induces the Apoptosis of Breast Cancer Cells by Nuclear EGFR/Stat3-Mediated c-Myc Downregulation
por: Kim, Ji-Hyang, et al.
Publicado: (2021)

Comparison of Intranasal Ciclesonide, Oral Levocetirizine, and Combination Treatment for Allergic Rhinitis
por: Kim, Chang-Hoon, et al.
Publicado: (2015)

Efficacy of ciclesonide in the treatment of patients with asthma exacerbation
por: Zietkowski, Ziemowit, et al.
Publicado: (2019)

Physalin A, 13,14-Seco-16, 24-Cyclo-Steroid, Inhibits Stemness of Breast Cancer Cells by Regulation of Hedgehog Signaling Pathway and Yes-Associated Protein 1 (YAP1)
por: Ko, Yu-Chan, et al.
Publicado: (2021)

Ciclesonide in persistent asthma: the evidence of its therapeutic value
por: Kenreigh, Charlotte A., et al.
Publicado: (2006)

A Case of Coronavirus Disease 2019 Treated With Ciclesonide
por: Nakajima, Kento, et al.
Publicado: (2020)

Is there a role for inhaled ciclesonide in the treatment of COVID-19?
por: Salvi, Sundeep Santosh
Publicado: (2021)

ABHD5 inhibits YAP-induced c-Met overexpression and colon cancer cell stemness via suppressing YAP methylation
por: Gu, Yan, et al.
Publicado: (2021)

Metabolism of ciclesonide in the upper and lower airways: review of available data
por: Nave, Ruediger, et al.
Publicado: (2008)

Ciclesonide: a safe and effective inhaled corticosteroid for the treatment of asthma
por: Schaffner, Timothy J, et al.
Publicado: (2009)

Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia
por: Mori, Nobuaki, et al.
Publicado: (2021)

Molecular pharmacology of ciclesonide against SARS-CoV-2
por: Kimura, Hirokazu, et al.
Publicado: (2020)

Inhaled ciclesonide for outpatients with COVID-19: A meta-analysis
por: Hsu, Chi-Kuei, et al.
Publicado: (2022)

BRD4/nuclear PD-L1/RelB circuit is involved in the stemness of breast cancer cells
por: Kim, Su-Lim, et al.
Publicado: (2023)

A randomized, double-blind study comparing the efficacy and safety of a combination of formoterol and ciclesonide with ciclesonide alone in asthma subjects with moderate-to-severe airflow limitation
por: Salvi, Sundeep S, et al.
Publicado: (2016)

A randomized, double-blind study comparing the efficacy and safety of a combination of formoterol and ciclesonide with ciclesonide alone in asthma subjects with moderate-to-severe airflow limitation
por: Barthwal, Madhu Sudan, et al.
Publicado: (2017)

Context-dependent roles of YAP/TAZ in stem cell fates and cancer
por: LeBlanc, Lucy, et al.
Publicado: (2021)

Ciclesonide Inhaler Treatment for Mild-to-Moderate COVID-19: A Randomized, Open-Label, Phase 2 Trial
por: Song, Joon-Young, et al.
Publicado: (2021)

Author Correction: ABHD5 inhibits YAP-induced c-Met overexpression and colon cancer cell stemness via suppressing YAP methylation
por: Gu, Yan, et al.
Publicado: (2023)

New treatment options in allergic rhinitis: patient considerations and the role of ciclesonide
por: Braido, F, et al.
Publicado: (2008)

112 Comparison of the Use Ciclesonide Versus Fluticasone for the Treatment of Asthma in Children
por: Oropeza, Said Arablin, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ms7t8rmoaoai8bvj7smmuhem8n